What is an 8-K filing and why is it important for investors?

An 8-K filing is a report of unscheduled material events or corporate changes that could be of importance to investors. It's often referred to as the 'special current report.' Its importance lies in providing timely disclosure of significant corporate developments that might affect a company's stock price or financial standing, allowing investors to make informed decisions.

What specific event is Boston Scientific reporting in this 8-K filing?

The provided text is a directory listing from the SEC's EDGAR system and does not contain the specific details of the event reported in the 8-K. To understand the exact nature of the event, investors would need to access and review the full 8-K filing document itself, which would detail the material event.

Where can I find the complete 8-K filing for Boston Scientific dated June 18, 1998?

The complete 8-K filing can typically be found on the SEC's EDGAR database, which is accessible through the SEC's website or via financial data providers. You would search for Boston Scientific Corp (BSX) and the filing date of June 18, 1998.

How can this 8-K filing impact Boston Scientific's stock?

The impact on Boston Scientific's stock would depend entirely on the nature of the material event disclosed in the 8-K. For example, a significant acquisition could be positive, while a product recall or a major lawsuit could be negative. Investors need to analyze the specific content of the filing to assess its potential effect on the company's valuation and future prospects.

BSX 8-K SEC Disclosure — Jun 18, 1998

Summary

This 8-K filing from Boston Scientific Corp (BSX), filed on June 18, 1998, provides an update on significant corporate events. While the specific details of the event are not fully elaborated within the provided text, the filing indicates that Boston Scientific is reporting material information to the SEC. Investors should note that 8-K filings are used to announce major corporate changes, which can include acquisitions, bankruptcies, resignations of key personnel, or amendments to corporate documents. Given the timing and the nature of an 8-K filing, this report likely relates to a development that could impact the company's financial performance, strategic direction, or stock valuation. Investors should consult the full filing, particularly the exhibits and any accompanying documents referenced, to understand the precise nature of the event and its potential implications for Boston Scientific's business and its shareholders.

Key Highlights

1Boston Scientific Corp (BSX) filed an 8-K Current Report on June 18, 1998.
2The event date associated with the filing is June 14, 1998.
38-K filings are used to report material events or corporate changes to the SEC.
4This filing signifies that a significant event has occurred that requires public disclosure.
5Investors should review the complete filing for details on the specific event and its potential impact.
6The provided text is a directory listing from the SEC's EDGAR system, not the full content of the 8-K.

BOSTON SCIENTIFIC CORP 8-K Report (Jun 18, 1998)

Summary

Key Highlights

Frequently Asked Questions